AN2 Therapeutics, Inc. also appointed two additional members to its Board of Directors, Patricia Martin and Stephanie Wong. Currently, Ms. Wong serves as Chief Financial Officer and Secretary of Calithera Biosciences. A former Eli Lilly and Company executive, Ms. Martin was the Chief Operating Officer of Lilly Diabetes as well as Lilly's corporate Chief Diversity Officer and Chief Alliance Officer.